Log in to save to my catalogue

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced c...

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1756db456d04ea59f57f4c24f50c6c9

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

About this item

Full title

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-11, Vol.12 (1), p.19660-14, Article 19660

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Multiple myeloma (MM) remains an incurable malignancy of plasma cells despite constantly evolving therapeutic approaches including various types of immunotherapy. Increased arginase activity has been associated with potent suppression of T-cell immune responses in different types of cancer. Here, we investigated the role of arginase 1 (ARG1) in Vκ*...

Alternative Titles

Full title

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c1756db456d04ea59f57f4c24f50c6c9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1756db456d04ea59f57f4c24f50c6c9

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-24137-1

How to access this item